Sphingolipids in disease
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Wien [u.a.]
Springer
2013
|
| Schriftenreihe: | Handbook of experimental pharmacology
216 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV040943092 | ||
| 003 | DE-604 | ||
| 005 | 20130521 | ||
| 007 | t| | ||
| 008 | 130412s2013 xx ad|| |||| 00||| eng d | ||
| 020 | |a 9783709115107 |9 978-3-7091-1510-7 | ||
| 035 | |a (OCoLC)844060127 | ||
| 035 | |a (DE-599)BVBBV040943092 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 | ||
| 084 | |a XI 1701 |0 (DE-625)152977:12907 |2 rvk | ||
| 245 | 1 | 0 | |a Sphingolipids in disease |c Erich Gulbins ..., ed. |
| 264 | 1 | |a Wien [u.a.] |b Springer |c 2013 | |
| 300 | |a VIII, 478 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Handbook of experimental pharmacology |v 216 | |
| 650 | 0 | 7 | |a Sphingolipide |0 (DE-588)4182242-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pathogenese |0 (DE-588)4115512-9 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Sphingolipide |0 (DE-588)4182242-0 |D s |
| 689 | 0 | 1 | |a Pathogenese |0 (DE-588)4115512-9 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Gulbins, Erich |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-3-7091-1511-4 |
| 830 | 0 | |a Handbook of experimental pharmacology |v 216 |w (DE-604)BV002390716 |9 216 | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-025921807 | |
Datensatz im Suchindex
| DE-19_call_number | 0700/4 Med. 8519(216 |
|---|---|
| DE-19_location | 50 |
| DE-BY-UBM_katkey | 4765007 |
| DE-BY-UBM_media_number | 41619784610012 |
| _version_ | 1823055240531804160 |
| adam_text | Contents
Part I Sphingolipids in Cancer
Sphingosine Kinase/Sphingosine 1-Phosphate Signaling in Cancer
Therapeutics and Drug Resistance
............................. 3
Shanmugam Panneer Selvam and Besim Ogretmen
Using ASMase Knockout Mice to Model Human Diseases
........... 29
Guoqiang
Hua
and Richard Kolesnick
New Perspectives on the Role of Sphingosine 1-Phosphate in Cancer
... 55
Susan Pyne and Nigel J. Pyne
Sphingolipids and Response to Chemotherapy
.................... 73
Marie-Thérèse Dimanche-Boitrel
and
Amélie Rebillard
Lung Cancer and Lung Injury: The Dual Role of Ceramide
......... 93
Tzipora Goldkom, Samuel Chung, and
Simone
Filosto
Sphingolipids Role in Radiotherapy for Prostate Cancer
........... 115
Carla
Hajj and
Adriana
Haimovitz-Friedman
Part II Sphingolipids in Cardio-Reno-vascular Diseases
Sphingolipid Metabolism and Atherosclerosis
.................... 133
Xian-Cheng Jiang and Jing Liu
Cardiovascular Effects of
Sphingosine-1-Phosphate
(SIP)
........... 147
Bodo Levkau
Cross Talk Between Ceramide and
Redox
Signaling: Implications for
Endothelial Dysfunction and Renal Disease
...................... 171
Ріп
-Lan
Li and Yang Zhang
viu
Contents
Part III Sphingolipids in Inflammation, Infection and Lung Diseases
Sphingolipids in Lung Endothelial Biology and Regulation
of Vascular Integrity
....................................... 201
Taimur Abbasi and Joe G.N. Garcia
Sphingolipids in Acute Lung Injury
............................ 227
Stefan Uhlig and Yang Yang
The Involvement of Sphingolipids in Chronic Obstructive
Pulmonary Diseases
........................................ 247
Irina
Petrache and
Daniela N.
Petrusca
Ceramide in Cystic Fibrosis
.................................. 265
Heike
Grassmé,
Joachim
Riethmüller,
and Erich Gulbins
Regulation of the Sphingosine Kinase/Sphingosine 1-Phosphate
Pathway
................................................. 275
K.
Alexa Orr
Gandy and Una M. Obeid
Bacterial Infections and Ceramide
............................. 305
Heike
Grassmé
and
Katrin Anne
Becker
Viral Infections and Sphingolipids
............................. 321
Jürgen
Schneider-Schaulies and
Sibylle Schneider-Schaulies
Ceramide in Plasma Membrane Repair
......................... 341
Annette Draeger and
Eduard
B. Babiychuk
Sphingolipids and Inflammatory Diseases of the Skin
.............. 355
Burkhard
Kleuser and
Lukasz Japtok
Sphingolipids in Obesity, Type
2
Diabetes, and Metabolic Disease
..... 373
S.B.
Russo,
J.S. Ross, and L.A. Cowart
Part IV Sphingolipids in Neuro-psychiatry and Muscle Diseases
Neuronal
Forms of
Gaucher
Disease
........................... 405
Einat B. Vitner and Anthony H.
Futerman
Sphingolipids in
Neuroinflammation
........................... 421
Laura Davies, Klaus
Fassbender,
and
Silke
Walter
Sphingolipids in Psychiatric Disorders and Pain Syndromes
......... 431
C.
Mühle,
M.
Reichel,
E.
Gulbins, and J. Kornhuber
Role of Sphingosine 1-Phosphate in Skeletal Muscle Cell Biology
..... 457
Paola Bruni
and
Chiara Donati
Index
................................................... 469
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV040943092 |
| classification_rvk | XI 1701 |
| ctrlnum | (OCoLC)844060127 (DE-599)BVBBV040943092 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01584nam a2200385 cb4500</leader><controlfield tag="001">BV040943092</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130521 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">130412s2013 xx ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783709115107</subfield><subfield code="9">978-3-7091-1510-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)844060127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040943092</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1701</subfield><subfield code="0">(DE-625)152977:12907</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sphingolipids in disease</subfield><subfield code="c">Erich Gulbins ..., ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Wien [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 478 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Handbook of experimental pharmacology</subfield><subfield code="v">216</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sphingolipide</subfield><subfield code="0">(DE-588)4182242-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pathogenese</subfield><subfield code="0">(DE-588)4115512-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Sphingolipide</subfield><subfield code="0">(DE-588)4182242-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pathogenese</subfield><subfield code="0">(DE-588)4115512-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gulbins, Erich</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-7091-1511-4</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Handbook of experimental pharmacology</subfield><subfield code="v">216</subfield><subfield code="w">(DE-604)BV002390716</subfield><subfield code="9">216</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025921807</subfield></datafield></record></collection> |
| id | DE-604.BV040943092 |
| illustrated | Illustrated |
| indexdate | 2025-02-03T17:41:49Z |
| institution | BVB |
| isbn | 9783709115107 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025921807 |
| oclc_num | 844060127 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | VIII, 478 S. Ill., graph. Darst. |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Springer |
| record_format | marc |
| series | Handbook of experimental pharmacology |
| series2 | Handbook of experimental pharmacology |
| spellingShingle | Sphingolipids in disease Handbook of experimental pharmacology Sphingolipide (DE-588)4182242-0 gnd Pathogenese (DE-588)4115512-9 gnd |
| subject_GND | (DE-588)4182242-0 (DE-588)4115512-9 |
| title | Sphingolipids in disease |
| title_auth | Sphingolipids in disease |
| title_exact_search | Sphingolipids in disease |
| title_full | Sphingolipids in disease Erich Gulbins ..., ed. |
| title_fullStr | Sphingolipids in disease Erich Gulbins ..., ed. |
| title_full_unstemmed | Sphingolipids in disease Erich Gulbins ..., ed. |
| title_short | Sphingolipids in disease |
| title_sort | sphingolipids in disease |
| topic | Sphingolipide (DE-588)4182242-0 gnd Pathogenese (DE-588)4115512-9 gnd |
| topic_facet | Sphingolipide Pathogenese |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002390716 |
| work_keys_str_mv | AT gulbinserich sphingolipidsindisease |